Three cases of pityriasis rubra pilaris successfully treated with cyclosporin A

被引：20

作者：

Usuki, K ^{[1
]}

Sekiyama, M ^{[1
]}

Shimada, T ^{[1
]}

Shimada, S ^{[1
]}

Kanzaki, T ^{[1
]}

机构：

[1] Kagoshima Univ, Fac Med, Dept Dermatol, Kagoshima 8908520, Japan

来源：

DERMATOLOGY | 2000年 / 200卷 / 04期

关键词：

pityriasis rubra pilaris; cyclosporin A; immunosuppressive agent;

D O I：

10.1159/000018397

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Background: Pityriasis rubra pilaris (PRP) is reported to respond poorly to cyclosporin A (CsA), Objective: We attempted to deter mine the efficacy of CsA in the treatment of classic adult-type PRP, Methods: Three patients with classic adult-type PRP were treated with 5 mg/kg/day CsA, Results: A sustained clinical response was achieved within 2-4 weeks of therapy. Relapses were noted when the CsA dose was decreased to 1.2 mg/kg/day. Conclusion: CsA should be considered in the treatment of classical adult-type PRP. Copyright (C) 2000 S. Karger AG, Baser.

引用

页码：324 / 327

页数：4

共 50 条

[41] Zidovudine in HIV-negative pityriasis rubra pilaris [J].

Griffiths, WAD ;

Hill, VA .

JOURNAL OF DERMATOLOGICAL TREATMENT, 1997, 8 (02) :127-131

[42] Drug-related pityriasis rubra pilaris with acantholysis [J].

Gajinov, Zorica T. ;

Matic, Milan B. ;

Duran, Verica D. ;

Vuckovic, Nada ;

Prcic, Sonja T. ;

Vujanovic, Ljuba M. .

VOJNOSANITETSKI PREGLED, 2013, 70 (09) :871-873

[43] Biologics for pityriasis rubra pilaris treatment: A review of the literature [J].

Napolitano, Monica ;

Abeni, Damiano ;

Didona, Biagio .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (02) :353-+

[44] Successful treatment with cyclosporine and guselkumab for pityriasis rubra pilaris [J].

Nishimura, Mai ;

Kondo, Makoto ;

Habe, Koji ;

Hayashi, Akinobu ;

Yamanaka, Keiichi .

CLINICAL CASE REPORTS, 2022, 10 (10)

[45] Dermoscopy for discriminating between pityriasis rubra pilaris and psoriasis [J].

Lallas, Aimilios ;

Apalla, Zoe ;

Karteridou, Anatoli ;

Lefaki, Ioanna .

JOURNAL OF DERMATOLOGICAL CASE REPORTS, 2013, 7 (01) :20-22

[46] Pityriasis rubra pilaris: An unusual cutaneous complication of AIDS [J].

Bonomo, RA ;

Korman, N ;

NagashimaWhalen, L ;

Briggs, J ;

Graham, R ;

Salata, RA .

AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1997, 314 (02) :118-121

[47] Exacerbation of pityriasis rubra pilaris under efalizumab therapy [J].

Klein, A. ;

Szeimies, R. -M. ;

Landthaler, M. ;

Karrer, S. .

DERMATOLOGY, 2007, 215 (01) :72-75

[48] Late onset pityriasis rubra pilaris type IV treated with low-dose acitretin [J].

Mota, Fernando ;

Carvalho, Sandrina ;

Sanches, Madalena ;

Selores, Manuela .

ACTA DERMATOVENEROLOGICA ALPINA PANNONICA ET ADRIATICA, 2016, 25 (01) :15-17

[49] Differentiation of pityriasis rubra pilaris from plaque psoriasis by dermoscopy [J].

Jha, Abhijeet Kumar ;

Lallas, Aimilios ;

Sonthalia, Sidharth ;

Jhakar, Deepak ;

Udayan, Uday K. ;

Chaudhary, R. K. P. .

DERMATOLOGY PRACTICAL & CONCEPTUAL, 2018, 8 (04) :299-302

[50] Pityriasis Rubra Pilaris (PRP): A case report of Type II [J].

Rajeh, Malak S. ;

Al-gethami, Mariyyah A. ;

Andijani, Mariam A. ;

Alsehly, Lina M. ;

Al Hawsawi, Khalid A. .

MEDICAL SCIENCE, 2020, 24 (102) :686-690

← 1 2 3 4 5 →